{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:07Z","timestamp":1789011547725,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008670","name":"Terumo Foundation for Life Sciences and Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bcmd.2021.102564","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T02:38:11Z","timestamp":1616553491000},"page":"102564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity"],"prefix":"10.1016","volume":"89","author":[{"given":"Angela","family":"Ugwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Iloanusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngozi","family":"Ugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barth","family":"Chukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osita","family":"Ezenwosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Modebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Duru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anazoeze","family":"Madu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezinne","family":"Chibueze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Igboke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obiora","family":"Ejiofor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chilota","family":"Efobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Uchendu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iheanyi","family":"Okpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcmd.2021.102564_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102564_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00247-004-1282-9","article-title":"Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?","volume":"35","author":"Jones","year":"2005","journal-title":"Pediatr. Radiol."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102564_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4329\/wjr.v7.i2.52","article-title":"Transcranial Doppler screening in sickle cell disease: the implications of using peak systolic criteria","volume":"7","author":"Naffaa","year":"2015","journal-title":"World Journal of Radiology."},{"issue":"6","key":"10.1016\/j.bcmd.2021.102564_bb0020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102564_bb0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0463.2011.02751.x","article-title":"Pilot study of omega-3 fatty acid supplements in sickle cell disease","volume":"119","author":"Okpala","year":"2011","journal-title":"APMIS."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102564_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3945\/ajcn.112.036319","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"16","key":"10.1016\/j.bcmd.2021.102564_bb0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJM197210192871606","article-title":"Cyanate as an inhibitor of red-cell sickling","volume":"287","author":"Deykin","year":"1972","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2021.102564_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0891-5849(91)90156-W","article-title":"Op den Kamp JA. Increased n-3 polyunsaturated fatty acid content of red blood cells from fish oil-fed rabbits increases in vitro lipid peroxidation, but decreases hemolysis","volume":"11","author":"van den Berg","year":"1991","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102564_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.moh.0000190108.62414.06","article-title":"Leukocyte adhesion and the pathophysiology of sickle cell disease","volume":"13","author":"Okpala","year":"2006","journal-title":"Curr. Opin. Hematol."},{"issue":"6","key":"10.1016\/j.bcmd.2021.102564_bb0050","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood.V98.6.1955","article-title":"P-selectin mediates the adhesion of sickle erythrocytes to the endothelium","volume":"98","author":"Matsui","year":"2001","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2021.102564_bb0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s002470000317","article-title":"Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation","volume":"30","author":"Bulas","year":"2000","journal-title":"Pediatric Radiol."},{"issue":"4","key":"10.1016\/j.bcmd.2021.102564_bb0060","first-page":"227","article-title":"Youth of West Cameroon are at high risk of developing IDD due to low dietary iodine and high dietary thiocyanate","volume":"8","author":"Taga","year":"2008","journal-title":"African Health Sciences"},{"issue":"2","key":"10.1016\/j.bcmd.2021.102564_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1677\/joe.0.1710259","article-title":"Effect of eicosapentaenoic acid ethyl ester on hypothyroid function","volume":"171","author":"Makino","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcmd.2021.102564_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/236374","article-title":"Addition of multimodal therapy to standard management of steady state sickle cell disease","volume":"2013","author":"Okpala","year":"2013","journal-title":"ISRN Hematology."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102564_bb0075","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4314\/ahs.v14i2.22","article-title":"Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study","volume":"14","author":"Madu","year":"2014","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.bcmd.2021.102564_bb0080","series-title":"Synopsis of Hematology","first-page":"47","article-title":"Sickle cell disease and thalassaemia","author":"Okpala","year":"2010"},{"key":"10.1016\/j.bcmd.2021.102564_bb0085","series-title":"Practical Management of Haemoglobinopathies","first-page":"20","article-title":"Epidemiology, genetics and pathophysiology of sickle cell disease","author":"Okpala","year":"2004"},{"key":"10.1016\/j.bcmd.2021.102564_bb0090","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0000000000000540","article-title":"Mechanisms of alloimmunization in sickle cell disease","volume":"26","author":"Hudson","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2021.102564_bb0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000369513","article-title":"Red blood cell alloimmunization in sickle cell disease: listen to your ancestors","volume":"41","author":"Campbell-Lee","year":"2014","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.bcmd.2021.102564_bb0100","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/bloodadvances.2018020594","article-title":"A locus on chromosome 5 shows African ancestry\u2013limited association with alloimmunization in sickle cell disease","volume":"2","author":"Williams","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2021.102564_bb0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.plefa.2005.03.005","article-title":"Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids","volume":"72","author":"Ren","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bcmd.2021.102564_bb0110","doi-asserted-by":"crossref","first-page":"5987082","DOI":"10.1155\/2017\/5987082","article-title":"Omega-3 polyunsaturated fatty acids in critical illness: anti-inflammatory, proresolving, or both?","volume":"2017","author":"Molfino","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bcmd.2021.102564_bb0115","series-title":"Resolvins and Protectins: Chemistry and Biology","first-page":"1","author":"Christie","year":"2011"},{"issue":"1","key":"10.1016\/j.bcmd.2021.102564_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0268-960X(03)00037-7","article-title":"The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder","volume":"18","author":"Okpala","year":"2004","journal-title":"Blood Rev."},{"issue":"6","key":"10.1016\/j.bcmd.2021.102564_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2796.1993.tb01000.x","article-title":"Acute phase reactants and severity of homozygous sickle cell disease","volume":"233","author":"Hedo","year":"1993","journal-title":"J. Intern. Med."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:36:14Z","timestamp":1761050174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979621000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":25,"alternative-id":["S1079979621000309"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102564","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102564"}}